David Jin - 30 Jun 2023 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Role
Interim PFO and COO
Signature
/s/ David Jin
Issuer symbol
ATXI
Transactions as of
30 Jun 2023
Net transactions value
$0
Form type
4
Filing time
05 Jul 2023, 16:09:29 UTC
Previous filing
14 Feb 2023
Next filing
22 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATXI Employee stock option (right to buy) Award $0 +250,000 $0.000000 250,000 30 Jun 2023 Common Stock 250,000 $1.14 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in accordance with the following schedule: (i) 25% of the shares subject to the option vest on August 1, 2023; (ii) 25% of the shares subject to the option vest on August 1, 2024; (iii) 25% of the shares subject to the option vest on August 1, 2025; and (iv) 25% of the shares subject to the option vest on August 1, 2026.
F2 Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.